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Abstract
Background: The innate immune response of urinary tract is critically important in the defense to microbial attack.
Toll-like receptor 4 (TLR4) controls initial mucosal response to uropathogenic Escherichia coli (UPEC). However,
excessive and dysfunctional TLR signaling may result in severe inflammation and inappropriate tissue damage.
Previous studies have demonstrated that single immunoglobulin IL-1R-related receptor/Toll IL-1 receptor 8
(SIGIRR/TIR8) is a member of the toll-interleukin-1 receptor (TIR) family that can negatively modulate TLR4
mediated signaling, but its role in the innate immunity of urinary tract infection remains incompletely
defined. In this study, we investigated its cellular distribution and mechanisms involved within the human
bladder epithelial cells after LPS stimulation.
Results: Immunostaining, reverse transcription PCR and Western blot results showed that SIGIRR was
constitutively expressed in the human bladder epithelial cell lines and was downregulated after LPS
stimulation. To further define the role of SIGIRR, cells were transiently transfected with SIGIRR siRNA and
stimulated with LPS. SIGIRR gene silencing augmented chemokine expression in response to LPS, as indicated
by increased levels of IL-6 and IL-8 secretions in the supernatants compared with negative control siRNA.
Furthermore, LPS tolerance, a protective mechanism against second LPS stimulation, was significantly reduced
in SIGIRR siRNA transfected cells. Moreover, transient gene silencing augmented LPS-induced NF-κB and MAPK
activation.
Conclusions: In conclusion, our results suggest that SIGIRR plays an important role in the negative regulation
of LPS response and tolerance in human bladder epithelial cells, possibly through its impact on TLR-mediated
signaling.
Keywords: Urinary tract infection, Human bladder epithelial cells, Toll like receptor, Single immunoglobulin
IL-1R-related receptor, Lipopolysaccharide, Endotoxin tolerance
Background
Urinary tract infections (UTIs) are among the most
common bacterial infections in humans and account for
significant morbidity and mortality. About 50 % of
women will experience at least one UTI in their lifetime,
and about 25 % of them will suffer from one or more
recurrent infections [1]. UTIs are caused by a number of
bacterial pathogens and uropathogenic Escherichia coli
(UPEC) remains the predominant uropathogen isolated
in community-acquired uncomplicated infections (80 %)
and hospital-acquired (50 %) infections [2–5]. Although
our knowledge about pathogenesis of UTIs has advanced
greatly in recent years, the precise mechanisms of spe-
cific host-pathogen interaction are not well understood.
Bladder epithelial cells (BECs) act as the first line of
defense against ascending pathogens. BECs can recognize
conserved pathogen-associated molecular patterns (PAMPs)
via several kinds of pattern recognition receptors
(PRRs), including Toll-like receptors (TLRs) which can
control the innate host defense at mucosal surfaces and
protect the mucosal barrier against bacterial attack.
Several Toll-like receptors (TLRs) have been identified
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in bladder epithelial cells including TLR4, which recog-
nizes lipopolysaccharide (LPS) from Gram-negative bac-
teria and plays a key role in inducing the inflammatory
responses elicited by UPEC [6–11]. Upon stimulation
by LPS, TLR4 initiates a signaling cascade involving
myeloid differentiation factor 88 (MyD88), IL-1R
associated kinases (IRAKs) and tumor necrosis factor
receptor-associated factor 6 (TRAF6), leads to activa-
tion of nuclear factor kappa B (NF-κB) and mitogen-
activated protein (MAP) kinases p38, JNK and
ERK1/2 [12, 13]. Then transcriptions of various cyto-
kines were stimulated including IL-6 and IL-8, two
of the major cytokines that are constitutively pro-
duced by urinary epithelial cells following the bacterial
infection [14, 15].
Although the TLR-mediated inflammatory response
is critical for host defense against pathogenic bacteria,
excessive and dysfunctional TLR signaling may result
in severe inflammation and inappropriate tissue dam-
age. Therefore, the intensity and duration of TLR re-
sponses must be tightly controlled. In fact, a number
of negative regulators of TLRs have been identified
[16], including single immunoglobulin IL-1R-related
receptor/Toll IL-1 receptor 8 (SIGIRR/TIR8) which is
a member of TLR/IL-1R superfamily and has been re-
ported to inhibit NF-κB and JNK activation following
stimulation of TLR family members, including TLR4
[17, 18]. The inhibitory activity was associated with
trapping of IRAK-1 and TRAF-6 [18, 19]. Overexpres-
sion of SIGIRR reduced TLR-mediated activation of
NF-κB and attenuated the production of inflammatory
cytokines in vitro. In SIGIRR-deficient mice, LPS in-
duced inflammatory responses were also enhanced
[18]. The high expression of SIGIRR in epithelial cells
indicates that SIGIRR may serve mainly to dampen
the immune response in cells that are continually exposed
to microorganisms [18, 20–24]. Although SIGIRR was re-
cently shown to regulate inflammation in a mouse model
of UTI in tubular epithelial cells [25], the cellular distribu-
tion and mechanisms involved within the human bladder
epithelial cells after LPS stimulation remain incompletely
defined.
In the present study, we characterized SIGIRR expres-
sion and modulation in human bladder epithelial cells,
and investigated the role of SIGIRR in regulating the im-
mune responsiveness during inflammation induced by
LPS. Our results suggest that SIGIRR is constitutively
expressed in human bladder epithelial cell lines and is
downregulated after LPS stimulation. Lack of SIGIRR re-
sults in increased production of proinflammatory cyto-
kines, and SIGIRR gene silencing cells have strikingly
impaired LPS tolerance, showing that SIGIRR nega-
tively regulates TLR signaling in human bladder epi-
thelial cells.
Results
Induction of IL-6 and IL-8 secretions by LPS in human
bladder epithelial cell lines
The two human bladder epithelial cell lines were stimu-
lated with LPS, and the levels of IL-6 and IL-8 in the
culture supernatants were determined by ELISA. The
time courses and dose dependency of IL-6 and IL-8 in-
ductions are shown in Fig. 1. T24 and 5637 cells
responded to LPS in a time and dose dependent manner,
IL-6 and IL-8 levels were upregulated strongly in T24
cells and weakly in 5637 cells. Thus, the bladder epithe-
lial cell lines appear to be uniformly LPS responsive, in
contrast to renal epithelial cells, which are non-
responsive to purified LPS [26]. As the two cell lines
showed a sufficient response to ≥ 100 ng/ml LPS, this
concentration was used in the remaining experiments.
SIGIRR expression and alteration in human bladder
epithelial cell lines
To determine the presence of SIGIRR in T24 and 5637
cells and its modulation after LPS stimulation, we first
tested SIGIRR mRNA and protein expression levels in
the two cell lines using RT-PCR and Western blot re-
spectively. The results suggest that SIGIRR is constitu-
tively expressed (mRNA and protein) in nonstimulated
cells (Fig. 2a and b). In addition, immunostaining
analysis was performed for the detection of SIGIRR
expression in human bladder epithelial cells. Confocal
fluorescence images showed the localization of SIGIRR in
the cell nuclear membrane and cytoplasm (Fig. 2c). To
verify the influence of LPS stimulation on SIGIRR expres-
sion, we incubated the cells with 100 ng/ml LPS for indi-
cated time courses. According to the results, SIGIRR
mRNA was significantly downregulated after incubation
with LPS for 6–12 h, and started to return to baseline
levels after 24 h (Fig. 3a and b). Similar results were
observed for protein levels (Fig. 3c and d).
SIGIRR gene silencing augmented inflammatory response
to LPS
Previous studies demonstrate that SIGIRR deficiency
leads to augmentation of TLR signaling. To clarify
whether SIGIRR functions as a negative regulator in LPS
stimulated bladder epithelial cells, we used a gene
knockdown method with siRNA targeting SIGIRR. Cells
were transfected with SIGIRR siRNA or negative control
siRNA, then the efficiency of target gene knock-down
was evaluated, which showed inhibition of SIGIRR
expression by approximately 70–80 % in T24 and
5637 cells compared to the negative control siRNA
(Fig. 4a and b). The effect of SIGIRR knockdown
was maximal at 48–72 h post-transfection, and the
reminder gene silencing studies were conducted within
these time points. After confirming siRNA efficiency, the
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transfected cell lines were treated with or without LPS for
6 h, after which the IL-6 and IL-8 productions in culture
supernatants were examined by ELISA. LPS mediated IL-
6 and IL-8 productions in the targeted siRNA-treated cells
were significantly greater than that in the negative control
siRNA-treated cells (Fig. 5a), indicating that SIGIRR
expressed in T24 and 5637 cells functions as a negative
regulator of TLR-4 signaling.
Enhanced TLR signaling in SIGIRR siRNA transfected cells
TLR stimulation activates NF-κB, JNK, p38 and ERK1/2
through the signaling molecules MyD88 and IRAK. We
therefore examined the activation of these downstream
effectors of TLR signaling in SIGIRR siRNA transfected
cells. SIGIRR siRNA transfected cells were stimulated
with LPS, and the activation of NF-κB, JNK, p38 and
ERK1/2 were analyzed. Phosphorylations of JNK, p38
and ERK1/2 were faster and stronger in SIGIRR siRNA
transfected cells than negative control siRNA transfected
cells, indicating enhanced signaling in LPS-stimulated
SIGIRR siRNA transfected cells and suggesting that
SIGIRR negatively regulates these signaling pathways
(Fig. 5b).
Involvement of SIGIRR in LPS induced tolerance
Our results showed that SIGIRR is a negative regulator of
TLR signaling which suggested that SIGIRR might be in-
volved in the induction of LPS tolerance. To examine this,
SIGIRR and negative control siRNA transfected cells were
first stimulated with 100 ng/ml of LPS (primary LPS stimu-
lation) or medium. After incubation for the indicated
period (24 h), cells were restimulated with 100 ng/ml LPS
(second LPS stimulation) for 6 h, the IL-6 and IL-8 con-
centrations in the supernatants were measured by ELISA.
The levels of IL-6 and IL-8 were significantly reduced in
cultures that had been pretreated with LPS for 24 h (Fig. 6).
These data demonstrated that LPS tolerance can be in-
duced in human bladder epithelial cells by pretreatment of
the cells with LPS. However, SIGIRR siRNA transfected
cells showed an impaired LPS tolerance, as the cytokine
levels produced upon LPS restimulation in SIGIRR siRNA
transfected cells were significantly higher than that in re-
stimulated negative control transfected cells (Fig. 6).
Discussion
In the present study, we examined the expression of
SIGIRR in human bladder epithelial cells (BECs) and its
(See figure on previous page.)
Fig. 1 Induction of IL-6 and IL-8 in T24 and 5637 by LPS stimulation. a Cells were stimulated with log increments of LPS between 0 ng/ml and
1000 ng/ml, the supernatant levels of IL-6 and IL-8 were determined 6 h after incubation with LPS by ELISA, *p < 0.05 versus 0 ng/ml. b Cells were
stimulated with 100 ng/ml LPS for 24 h, the supernatant levels of IL-6 and IL-8 measured by ELISA at the indicated times, *p < 0.05 versus 0 h.
Experiments were performed at least three times in triplicate. Data represent the means ± SEM
Fig. 2 SIGIRR expression and localization in T24 and 5637 cells. SIGIRR mRNA expression (a) and protein expression (b) were detected by RT-PCR
and Western blot in T24 and 5637 cells respectively. c Immunofluorescent stainning analysis showed that SIGIRR was localized in the cell nuclear
membrane and cytoplasm
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alteration during inflammation. Our results suggested
that SIGIRR gene silencing caused an increased response
to LPS, in terms of exaggerated production of proinflam-
matory cytokines which was associated with enhanced
TLR signaling and impaired tolerance to LPS. These are
the first known results to shown the role of SIGIRR in
human bladder epithelial cells during inflammatory re-
sponse induced by LPS.
Single immunoglobulin IL-1-related receptor, also
known as Toll IL-1 receptor 8 (SIGIRR/TIR8), is one of
the transmembrane negative regulators of TLR signaling.
SIGIRR is constituted by a single Ig extracellular domain
with several N- and O-glycosylation sites, a transmem-
brane domain, an intracellular conserved TIR domain
and a 95 amino acid-long tail at the C-terminal [17, 27].
Although SIGIRR has highly conserved TIR domain, it
does not contain two amino acids (Ser447 and Tyr 536,
replaced by Cys222 and Leu305), which were essential
for the IL-1R signaling. The tissue expression of SIGIRR
is ubiquitous, in particularly in kidney, digestive tract,
liver, lung and lymphoid organs [17, 28], its cell-type ex-
pression is more specific, with extremely high expression
in epithelial cells lines [18]. Thus it seems that SIGIRR
regulates the immune response mainly at epithelial and
mucosal sites. In this study, the expression of SIGIRR in
T24 and 5637 cell lines, which are human bladder
epithelial cell lines, were detected by immunostaining,
RT-PCR and Western blot. We chose to use T24 and
5637 cells as they are similar to primary human bladder
epithelial cells in that they express TLR4 and are sensi-
tive to stimulation by LPS and E.coli [10, 14, 29, 30]. We
found that SIGIRR was constitutively expressed in T24
and 5637 cells in mRNA and protein levels. Confocal
fluorescence microscopy demonstrated that SIGIRR was
expressed in the cell nuclear membrane and cytoplasm.
These findings are consistent with earlier studies in
which SIGIRR were stably overexpressed in human in-
testinal and airway epithelial cells [31, 32]. The location
in human bladder epithelial cell lines suggests that
SIGIRR may participate in the epithelial immune re-
sponse during inflammation.
Previous studies found that murine and human SIGIRR
expression were usually down-regulated by LPS stimula-
tion or in other inflammatory conditions. For instance,
SIGIRR expression was down-regulated at 6 and 12 h in
mice after injection of a low dose of LPS in lung and
Fig. 3 Downregulation of SIGIRR expression after LPS stimulation. a and b Changes in SIGIRR mRNA expression in T24 and 5637 cells after LPS
stimulation at the indicated times were analyzed by real-time PCR. Data represent the means ± SEM from three independent experiments,
*p < 0.05 versus 0 h. c and d Changes in SIGIRR protein expression in T24 and 5637 cells were analyzed by Western blot
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kidney [18, 28]. A similar result showing the alteration of
SIGIRR expression was also observed in the lung upon
Pseudomonas aeruginosa infection or in the intestinal epi-
thelial cells during inflammation in human ulcerative col-
itis [22, 33]. Our findings of decreased expression of
SIGIRR following LPS stimulation are in concordance
with previous studies. Real-time PCR analysis revealed
that SIGIRR mRNA levels started to decrease at 3 h after
exposure to LPS, reached the lowest level at about 6 h,
and returned to baseline by 24 h after the cell recovered
from LPS stimulation. Similar results were observed for
protein levels. This was consistent with the findings in
kidney that SIGIRR mRNA was significantly downregu-
lated at early time points and started to increase toward
baseline levels at later time point after UTI [34]. It seems
that the downregulation is dependent upon decrease in
binding of the transcription factor SP1 at the responsive
element of the SIGIRR promoter. In the presence of LPS,
the binding of SP1 to SIGIRR promoter consensus sites
was reduced, resulting in transient inhibition of SIGIRR
expression in epithelial cells [22]. It can be speculated that
this downregulation would enhance an inflammatory
response against urinary infection or elimination of
microbes during tissue damage. While the subsequent up-
regulation could, in turn, ameliorate collateral damage
due to an exaggerated or prolonged inflammatory re-
sponse. However, LPS or cytokine exposure rather upre-
gulates SIGIRR in monocytes in contrast with tubular
epithelial cells, a finding consistent with the observation
of SIGIRR expression in monocytes of patients with sepsis
and cardiac arrest (RCA). This cell type-specific regulation
may be associated with N- and O- glycosylation of SIGIRR
in different cell origins [27, 35].
The pattern of SIGIRR consumption may indicate its
functional involvement in ameliorating inflammation.
Gene-targeted studies demonstrate that SIGIRR acts
as a nonredundant negative regulator in dampening
IL-1R and TLR-induced inflammation and tissue dam-
age, including tuberculosis, candidiasis, aspergillosis,
Pseudomonas aeruginosa infection and endotoxemia
Fig. 4 Transient gene silencing reduces SIGIRR expression in T24 and 5637 cells. Cells were transfected with SIGIRR and negative control siRNA in
transfection reagents. Efficiencies of SIGIRR siRNA for target gene expression knock-down in cells were evaluated by real-time PCR (a) and Western
blot (b). The mRNA levels of SIGIRR expression in each of the samples were normalized by GAPDH and compared to that of the negative control
siRNA, *p < 0.05 versus negative control siRNA
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[18, 23, 33, 36, 37]. Next, in order to elucidate the
role of SIGIRR in BECs innate immune response, we
knocked-down SIGIRR expression by using gene si-
lencing and found that inflammation was exacerbated
by an elevated productions of IL-6 and IL-8 after the
cells were stimulated with LPS. These findings indicate
clearly that decreased expression of SIGIRR causes a sig-
nificant enhancement of inflammatory response in BECs
by dysregulating innate immunity. Previous mechanistic
studies indicate that SIGIRR blocks TLR4 signaling by se-
questering IL-1 receptor-associated kinase (IRAK) and
tumor necrosis factor (TNF) receptor-associated (TRAF)
6, which are the key signaling proteins causing activation
of NF-κB, JNK, p38, and ERK1/2 [19]. Therefore, the
exacerbated response of SIGIRR siRNA transfected cells is
likely the result of enhanced TLR signaling. Consistent
with this, SIGIRR siRNA transfected BECs stimulated with
LPS displayed increased NF-κB and MAP kinase activa-
tion, both well-characterized outputs of TLR stimulation.
Our findings demonstrate that SIGIRR is an important
negative regulator of LPS-induced BECs activation.
Similar function was observed in modulation of adaptive
immunity by effectively inhibiting IL-33 induced ERK,
JNK, p38 and IκB phosphorylation and fine-tuning type1/
type2 inflammation response [33, 38].
A prior exposure to bacterial products such as lipo-
polysaccharide (LPS) may induce a transient state of
refractoriness to subsequent challenge that has been
Fig. 5 SIGIRR gene silencing augmented inflammatory response and signaling upon LPS stimulation. a Increased response in SIGIRR gene
silencing cells upon LPS stimulation. SIGIRR and negative control siRNA transfected cells were exposed to 100 ng/ml LPS, cell culture supernatants
were collected after 6 h, levels of IL-6 and IL-8 were quantified by ELISA. Data represent the means ± SEM from three independent experiments,
*p < 0.05 versus negative control siRNA. b Increased signaling in SIGIRR gene silencing cells upon LPS stimulation. SIGIRR and negative control
siRNA transfected cells were stimulated with 100 ng/ml LPS for the indicated periods. Cells lysates were blotted with the indicated antibodies
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referred to as “tolerance”. Tolerance has been postulated
as a protective mechanism limiting excessive inflamma-
tion and preventing septic shock [39]. The molecular
mechanism of endotoxin tolerance is complicated, mul-
tiple mechanisms are involved including the deficient re-
cruitment of the adaptor MyD88 to TLR4, decreased IL-
1 receptor-associated kinase (IRAK) 4-MyD88 associ-
ation, deficient IRAK1 activation, upregulation of nega-
tive regulators such as IRAK-M, suppressor of cytokine
signaling 1 (SOCS-1), ST2 and SHIP [40–46]. Generally
speaking, “tolerance” has a much more specific meaning
in immune cells like monocyte/macrophage. Since “LPS
tolerance” has been mentioned in the previous investiga-
tion on the ability of bladder epithelial cells to become
tolerant to LPS stimulation, we used this term in our
study [14]. With its high expression in epithelial cells
and negative role in TLR signaling, we suppose that
SIGIRR may play a critical role in the maintenance
of innate immune tolerance to microbes. We found
that BECs which were prestimulated with LPS had
significantly reduced response to LPS, the results
demonstrated that LPS tolerance can be induced in
uroepithelial cells, which was consistent with previ-
ous report [14]. Moreover, SIGIRR siRNA transfected
cells were significantly impaired in the development
of tolerance upon repeated stimulation with LPS,
which suggested the involvement of SIGIRR in LPS
tolerance. Our results indicate that SIGIRR may be an im-
portant modulator in controlling the homeostasis and in-
nate immune response of uroepithelium to bacterial
products. Future studies are required to dissect its role in
the mechanism and crosstalk of endotoxin tolerance.
Conclusions
Taken together, we have identified the expression of
SIGIRR in human bladder epithelial cell lines and its al-
teration after LPS stimulation. The negative role of
SIGIRR in Toll like receptor signaling and its involve-
ment in LPS tolerance in human uroepithelial cells indi-
cate that SIGIRR is an important feedback regulator of
innate immunity and plays a critical role in maintenance
of epithelium homeostasis.
Fig. 6 SIGIRR is required for LPS tolerance in T24 and 5637 cells. LPS tolerance was induced in SIGIRR and negative control siRNA cells by
pretreatment with 100 ng/ml LPS (1st LPS) for 24 h or maintained in medium. After 24 h, the cells were washed with fresh medium and
restimulated with 100 ng/ml LPS (2nd LPS) for 6 h. The levels of IL-6 and IL-8 in the supernatants were measured by ELISA. Experiment were
repeated at least three times in triplicate with similar results, #p < 0.05 with respect to the same treatment but without pretreatment with LPS,
*p < 0.05 versus negative control siRNA with the same treatment
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Methods
Cell culture
Human bladder epithelial T24 and 5637 cell lines were
obtained from the Shanghai Institute of Cell Biology,
Chinese Academy of Sciences. Cells were maintained in
RPMI1640 medium (Gibco BRL, Gaithersburg, MD,
USA) supplemented with 10 % fetal bovine serum
(Hyclone, Logan, Utah), 2 mM L-glutamine, 100 IU/ml
penicillin and 100 μg/ml streptomycin at 37 °C in a
humidified atmosphere of 95 % air and 5 % CO2.
Immunofluorescent staining
Immunofluorescent analyses of SIGIRR expression in
T24 and 5637 cells were performed as follows. Cells
were fixed with 4 % paraformaldehyde and then perme-
abilized with 0.2 % Triton X-100. After being blocked
with 5 % BSA, cells were incubated with anti-SIGIRR
antibody (1:100, Santa Cruz, CA, USA) at 4 °C overnight.
The next day, after being washed with PBS, cells were in-
cubated with a FITC-conjugated anti-goat secondary anti-
body (1:200, Beyotime, China) for 2 h and then stained
with DAPI (Beyotime, China). Cells were analyzed under a
confocal microscope (Leica SP1 and Leica SP2 UV, Leica
Microsystem).
RNA extraction and reverse transcription-polymerase
chain reaction
Total RNAs were isolated using Trizol reagent (Invitrogen
Corp., Carlsbad, CA, USA), according to the manu-
facturer’s instructions. cDNA was generated using
PrimeScript RT reagent kit (Takara Biotechnology
Co., Dalian, China) according to the manufacturer’s
protocol, which was then amplified by PCR using spe-
cific primers for SIGIRR (forward, 5′- GAG AGC
CGG AGC AGC GAA GT -3′; reverse, 5′- CCT
GTT GAG CAG AGG AGC GA-3′, 173 bp) and β-actin
(forward, 5′- CTC CAT CCT GGC CTC GCT GT-3′;
reverse, 5′-GCT GTC ACC TTC ACC GTT CC-3′,
268 bp). PCR conditions consisted of 26 cycles at 94 °C
for 30s, 58 °C for 30s, and 72 °C for 45 s for denaturation,
annealing, and extension, respectively, followed by a final
extension at 72 °C for 4 min. The PCR products were ana-
lyzed by electrophoresis on 2 % agarose gel.
Real-time quantitative polymerase chain reaction
The expression levels of SIGIRR gene were analyzed by
real-time quantitative PCR (Corbett Rotor-Gene), cells
were harvested after LPS stimulation at the indicated
times and siRNA transfection. Total RNAs were pre-
pared using Trizol Reagent (Invitrogen, Carlsbad, CA)
and cDNA was synthesized using the PrimeScript RT
reagent kit (Takara Biotechnology Co., Dalian, China)
according to the manufacturer’s protocol. Relative levels
of SIGIRR gene expression were assessed using the
SYBR Premix Ex Taq kit (Takara). Primers for real-time
PCR were as follows: SIGIRR, forward 5′- GAG AGC
CGG AGC AGC GAA GT -3′, reverse 5′- CCT GTT
GAG CAG AGG AGC GA -3′; glyceraldehyde 3-
phosphate dehydrogenase (GAPDH), forward 5′- CCA
CAT CGC TCA GAC ACC AT-3′, reverse 5′- TGA
CCA GGC GCC CAA TA-3′. Real-time PCR products
were analyzed by ΔΔCt method and all mRNA expression
levels were normalized to glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH) expression in the respective cDNA
preparation. All experiments were repeated three times in
triplicate.
Western blot
Cells were lysed with RIPA buffer (Sigma-Aldrich, St.
Louis, MO) supplemented with fresh protease inhibitor
phenylmethanesulfonyl fluoride on ice. Protein concen-
trations were measured using a BCA Protein Assay Kit
(Pierce Biotechnology Inc., Rockford, IL, USA). Protein
(50 μg) was boiled and loaded on 10 % sodium dodecyl
sulfate polyacrylamide gel electrophoresis and trans-
ferred to a PVDF membrane (Millipore, Bioprocess
Technology Center, Billerica, MA, USA). Membranes
were blocked in 5 % non-fat milk and incubated
overnight at 4 °C with the appropriate primary anti-
bodies at dilutions specified by the manufacturer.
Antibodies against SIGIRR, phospho-IκBα (p-IκBα),
phospho-ERK1/2 (p-ERK1/2), phospho-JNK (p-JNK),
phospho-p38 (p-p38), p-38 and β-actin were purchased
from Santa Cruz Biotechnology (California, USA). They
were next washed three times in 15 ml Tris-buffered sa-
line with Tween 20 (TBS-T) and incubated with the corre-
sponding horseradish peroxidase (HRP)-conjugated
secondary antibodies (Zhongshan Golden Bridge Biotech-
nology, Beijing, China) at 1:1000 dilution in TBS-T for 2 h
at room temperature with slightly shaking. Then the
bound secondary antibodies were detected using ECL
Western blotting Detection System (Amersham, Uppsala,
Sweden).
SIGIRR small interfering RNA transfection
Cells were seeded at the density of 2 × 105 cells/well in
six-well tissue culture plates. After incubation for 18–24
h, the cells (60–80 % confluence) were washed with PBS
and transiently transfected with SIGIRR specific small
interfering RNA (sc-61547; Santa Cruz Biotechnology,
CA, USA) or negative control siRNA (sc-37007; Santa
Cruz Biotechnology) mixed with transfection reagent
(sc-29528; Santa Cruz Biotechnology) according to the
manufacturer’s instructions. Fluorescein conjugated con-
trol siRNA (sc-36869) was used to monitor transfection
efficiency. Transfection medium (sc-36868) were also
purchased from Santa Cruz Biotechnology. At 48 and
72 h after transfection, real-time PCR and Western blot
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were used to determine the effectiveness of SIGIRR
siRNA in suppression of mRNA and protein levels.
Stimulation of human bladder epithelial cells and
induction of LPS tolerance
T24 and 5637 cells were seeded at the density of 2 × 105
cells/well in six-well tissue culture plates and grown to
confluence over 2 days. The cells were treated with
culture medium alone or medium containing 1 ng/ml,
10 ng/ml, 100 ng/ml or 1000 ng/ml of LPS (Escherichia
coli serotype O55:B5, Sigma-Aldrich, St. Louis, MO).
After incubation for 6 h, IL-6 and IL-8 levels in the
supernatants were determined by ELISA. Then the non-
stimulated cells were incubated with 100 ng/ml LPS for
24 h, culture supernatants were taken at 0, 3, 6, 12, 24 h
and assayed for IL-6 and IL-8 concentrations by ELISA.
LPS tolerance was induced by pretreatment with
100 ng/ml LPS (1st LPS). After 24 h, the supernatants
were removed and the cells were washed once with fresh
medium and restimulated with 100 ng/ml of LPS (2nd
LPS) for 6 h. The concentrations of IL6 and IL-8 in the
supernatants were evaluated by ELISA and compared
with that received the second stimulation alone.
Determination of IL-6 and IL-8 by ELISA
IL-6 and IL-8 concentrations in the culture supernatants
were measured by commercial ELISA kits (R&D Systems,
Minneapolis, MN) according to the manufacturer’s in-
structions. All samples were assayed in triplicate.
Statistical analysis
The data are presented as mean ± SEM. All statistical re-
sults were analyzed with Student’s t-test using GraphPad
Prism 5.0 (GraphPad Software, San Diego, CA). Differ-
ences were considered significant at the level of p < 0.05.
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